Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Finasteride may cause breast enlargement, low testosterone a risk factor.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The treatment effectively reduces hair loss and improves hair growth with minimal side effects.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Spironolactone is effective and safe for treating excessive facial hair in women.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Spironolactone did not make hair thinner in women with excess hair growth.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Zhuangyao Jianshen pill reduces prostate enlargement and inflammation in rats.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Spironolactone may reduce excessive hair growth in women but its effectiveness for acne is not supported.